Sort by
Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
61%
Diabetes
51%
Insulin
41%
Type 2 Diabetes Mellitus (T2DM)
38%
Glucose Transporter 1 (GLUT1)
31%
Hypoglycemia
31%
Children with Type 1 Diabetes
31%
Glucose Transporter 4 (GLUT4)
25%
Hemoglobin A1c (HbA1c)
24%
Diabetes Complications
22%
Metformin
21%
Glycemic Control
20%
Sheep
20%
Diabetes Control
20%
Diabetes Prevention Program
20%
Glucagon
17%
Insulin Resistance
16%
Young children
16%
Severe Hypoglycemia
16%
Wolfram Syndrome
15%
Treatment Options
15%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
14%
Hyperglycemia
14%
Transgenic Mice
14%
Developmental Programming
14%
HIV Protease Inhibitors
13%
Risk Factors
13%
Diabetes Epidemiology
13%
Catenin
13%
Diabetes Intervention
12%
Glucose Transport
12%
Insulin Sensitivity
11%
Protease Inhibitors
11%
Adolescents with Type 1 Diabetes
11%
Retinopathy
10%
X-linked Hypophosphatemia
10%
Overexpressing
10%
Older Adults
10%
Intensive Care Medicine
10%
Youth Studies
10%
Metabolic Control
10%
Insulin Independence
10%
Blood Glucose
10%
Plasma Glucose
9%
Pediatric
9%
Diabetic Ketoacidosis
9%
Diabetes Duration
9%
Cystic Fibrosis
9%
Diabetic
9%
Liver
9%
Program Outcomes
8%
Treatment Group
8%
Parental Diabetes
8%
Family Systems Therapy
8%
Burosumab
8%
Early-onset Type 2 Diabetes
8%
Skeletal muscle
8%
Cell Function
8%
Diabetes Management
8%
Epinephrine
7%
High-fat Diet
7%
Obesity
7%
Insulin Secretion
7%
Diabetic Retinopathy
7%
Brain Development
7%
Testosterone
7%
Placebo
6%
Insulin-dependent Diabetes
6%
Glucose Level
6%
Non-diabetic
6%
Conventional Therapy
6%
Hypertension
6%
Bioavailable Testosterone
6%
Insulin Therapy
6%
Syndromic Diabetes
6%
Clinical Trials
6%
Glucose Homeostasis
6%
Lyase
6%
Puberty
6%
Diabetic children
6%
Cardiovascular Disease
6%
Nocturnal Hypoglycemia
6%
Facilitative Glucose Transporter
6%
Hyperinsulinemia
6%
Obesogenic Diet
6%
Diabetic Patients
6%
Inflammation
5%
Continuous Glucose Monitoring
5%
Endoplasmic Reticulum Stress (ER stress)
5%
Lipids
5%
Non-alcoholic Fatty Liver Disease (NAFLD)
5%
Oral Glucose Tolerance Test
5%
Liver Regeneration
5%
Control Subjects
5%
Hypophosphatasia
5%
Overexpression
5%
Insulin Requirement
5%
Body Mass Index
5%
Conscious Dogs
5%
Medicine and Dentistry
Diabetes
58%
Insulin Dependent Diabetes Mellitus
55%
Maturity Onset Diabetes of the Young
35%
Diabetes Mellitus
19%
Pediatrics
18%
Diabetes Prevention
17%
Offspring
17%
Glycon
16%
Diseases
16%
Hemoglobin A1c
15%
Hypoglycemia
15%
Insulin Resistance
15%
Diabetes Control and Complications Trial
15%
Glucose Uptake
14%
X Linked Hypophosphatemic Rickets
13%
Treatment Option
12%
Diabetes in Adolescents
12%
Epidemiology of Diabetes
12%
Cardiovascular System
11%
Retinopathy
11%
Glycemic Control
11%
Intensive Care
10%
Glucose Transporter 4
10%
Body Mass Index
10%
Transgenic Mouse
10%
Wolfram Syndrome
9%
Glucose Transporter
8%
Glucose Transporter 1
8%
Human Immunodeficiency Virus Proteinase Inhibitor
8%
Diabetic Retinopathy
8%
Skeletal Muscle
8%
Cardiovascular Disease
8%
Hyperinsulinemia
8%
Insulin Release
8%
Hyperandrogenism
7%
Cystic Fibrosis
7%
Burosumab
7%
Vitamin D
7%
Severe Hypoglycemia
6%
Insulin Sensitivity
6%
Adverse Event
6%
Diabetic Ketoacidosis
6%
Hyperglycemia
6%
Lifestyle Intervention
6%
Impaired Glucose Tolerance
5%
Biological Marker
5%
In Vitro
5%
Hypophosphatasia
5%
Alkaline Phosphatase
5%
Endoplasmic Reticulum Stress
5%
Proteinase Inhibitor
5%
Rickets
5%
Prevalence
5%
C-Peptide
5%
Adverse Effect
5%
Bisphenol A
5%
Clinical Trial
5%
Knockout Mouse
5%
Disease
5%
Nonalcoholic Fatty Liver
5%
Blood Glucose
5%
Catenin
5%
Treatment Group
5%
Intrauterine Growth Retardation
5%